Leaders in Pharmaceutical Business Intelligence (LPBI) Group

SPEAKERS

• Andrew Adams, President, Publicis Health Solutions
• Derek Adams,PhD, Chief Technology & Manufacturing Officer, bluebird bio
• Dolores Baksh, PhD, Innovation Leader, Cell Therapy Technologies, GE Healthcare
• Ashvin Bashyam, PhD candidate in the Department of Electrical Engineering & Computer Science, MIT, Co-President, MIT Biotechnology Group
• Angela Belcher, PhD, James Mason Crafts Professor, Professor of Biological Engineering, Materials Science and Engineering, Koch Institute for Integrative Cancer Research, MIT
• Maria Berkman, MD, Director, Broadview Ventures
• Aaron Bernstein, PhD Candidate in Cellular & Molecular Physiology, Tufts University, President, Tufts Biomedical Business Club
• Kerrie Brady, Chief Business Officer, Centrexion
• Marta Bralic, Vice President of Business Development, Flatiron Health
• Caeleigh Brown
• Jim Burns, PhD, President & CEO, Casebia Therapeutics
• Abbie Celniker, PhD, Partner, Third Rock Ventures
• Anna Christo, Senior Director, Science and Technology, Alexandria Real Estate Equities, Inc.
• George Church, PhD, Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology
• Bob Coughlin, President & CEO, MassBio
• Agnieszka Czechowicz, MD, PhD, Assistant Professor of Pediatrics (Stem Cell Transplantation), Stanford University
• Matt Dallas, Chief Financial Officer, AVEO Pharmaceuticals
• Frank David, MD, PhD, Founder and Managing Director, Pharmagellan
• Mitch DeKoven, Principal, – Health Economics and Outcomes Research, Real World Insights, IQVIA
• Oliver Dodd, Co-Founder, Remora Therapeutics
• Alin Dragos, Digital Currency Initiative Product Management, MIT Media Lab
• Nick Eliovits, Managing Partner, Olive Tree Capital
• Jeff Elton, Managing Director and Global Head, Predictive Health Intelligence, Accenture
• Giovanna Fessenden, Of Counsel, Hamilton Brook Smith Reynolds
• Naomi Fried, PhD, Founder and CEO, Health Innovation Strategies
• Stephen Galebach, Galebach Law
• Brian Gallagher, Partner, SR One
• Brett Geiger, PhD candidate in the Department of Biological Engineering, MIT, Co-Presidents, MIT Biotech Group
• Rebecca Gibbs, PhD candidate in Biological and Biomedical Sciences, Harvard University, President, Harvard Biotech Club
• Michael Gibson, MD, CEO, Baim Institute for Clinical Research
• David Glass, PhD, D. Glass Associates
• Laurie Glimcher, MD, President and CEO, Dana-Farber Cancer Institute
• Marc Goldberg, Managing Director, BioVentures Investors
• Arjun Goyal, MD, Co-founder and Managing Director, Vida Ventures
• Aine Hanly, Vice President, Process Development and Massachusetts Site Head, Amgen
• Peter Hecht, PhD, CEO, Ironwood Pharmaceuticals
• Martin Heidecker, PhD, Director, Investment Manager, Boehringer Ingelheim Venture Fund
• Peter Hein, MD, PhD, External Innovation Lead and Director, Innovative Medicines Unit, Grünenthal
• Arthur Hiller, CEO, Antyllus Therapeutics, Inc., and Principal, Hiller Life Sciences Strategies, LLC
• Lori Hu, Principal, Vertex Ventures
• Laura Indolfi, PhD, CEO & Co-Founder, PanTher Therapeutics
• Matt Kapusta, CEO, uniQure
• Stephen Kennedy Smith, Principal Park Agency – Kennedy Enterprises
• Ash Khanna, PhD, Venture Partner, Pivotal bioVenture Partners
• Daniel Kohane, MD PhD, Boston Children’s Hospital
• Julie Krop, MD, Chief Medical Officer and Senior Vice President of Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals
• Robert Langer, ScD, the David H. Koch Institute Professor, MIT
• Harvey Lodish, PhD, Professor of Biology and Biological Engineering, MIT and Founding Member, Whitehead Institute
• David Lucchino, Co-Founder, President & CEO, Frequency Therapeutics
• Larry Lucchino, Boston Red Sox President/CEO Emeritus and Chairman of the Board, Jimmy Fund
• Anna Maiques, CEO, Neuroelectrics
• Eddie Martucci, CEO, Akili
• Frank McGillin, Chief Commercial Officer, NeuroMetrix
• Terry McGuire, Founding Partner, Polaris Partners
• Marian McKee, PhD, Senior Director and Head of Global Operational Development Services, MilliporeSigma
• Lindsay McNair, MD, Chief Medical Officer, WIRB-Copernicus Group
• Anne Mostue, Anchor, Reporter, Bloomberg News
• Christopher Murphy, Chief Manufacturing Officer, Brammer Bio
• Marian Nakada, PhD, Vice President, Venture Investments, Johnson & Johnson Innovation
• Dana Ono, PhD, Managing Partner, OLS Ventures
• Lucinda Orsini, Associate Chief Science Officer, International Society For Pharmacoeconomics and Outcomes Research
• Michio Painter, PhD, Co-Founder and CEO, Blue Therapeutics
• Maria Palasis, PhD, President & CEO, 480 Biomedical
• Catherine Parham, Vice President, Clinical Therapeutic Area Head, Shire
• Leila Pirhaji, PhD, CEO, ReviveMed Technologies
• Chandra Ramanathan, PhD, Head, East Coast Innovation Center, Bayer
• Jim Roach, MD, Chief Medical Officer, Pulmatrix
• Marc Rubenstein, Partner, Ropes & Gray
• Stephen Sallan, MD, Quick Family Chair, Pediatric Oncology, Dana Farber Cancer Institute
• Rev. Dr. James Sherblom
• Al Sokol, Partner, McDermott, Will & Emery
• Lesley Solomon, Senior Vice President Innovation, Chief Innovation Officer, Dana-Farber Cancer Institute
• Christopher de Souza, PhD, Director, Broadview Ventures
• Edie Stringfellow, Director of Diversity & Inclusion, MassBio
• John Tagliamonte, Chief Operation Officer, WntRx and EIR, MassBio Science
• Barry Ticho MD PhD, Chief Medical Officer, Stoke Therapeutics
• Praveen Tipirneni, MD, President & CEO, Morphic Therapeutic
• Ailis Tweed-Kent, MD, CEO, Cocoon Biotech & Attending Physician, Massachusetts General Hospital
• Stephen Ubl, President & CEO, PhRMA
• Akshay Vaishnaw, MD, PhD, Executive Vice President of R&D and Chief Medical Officer, Alnylam Pharmaceuticals
• Francois Valencony, General Manager, Mérieux Développement
• Ramani Varansai, President & CEO, X-Biotix Therapeutics, Inc.
• Terry Vance, Chief Business Officer, BioMotiv
• Alex Waldron, Chief Commercial Officer, Pear Therapeutics
• Russ Wilcox, Partner, Pillar
• Susan Windham-Bannister, PhD, President & CEO, Biomedical Growth Strategies
• Cissy Young, PhD, Managing Director, Russell Reynolds Associates

https://www.massbio.org/events/2018-massbio-annual-meeting-2487?tab=speakers

• Overview
• Agenda
• Speakers